We are live on ! Find out more
HLTH

Cue Health Inc. Common Stock

Delisted

HLTH was delisted on the 5th of June, 2024.

79 hedge funds and large institutions have $24.8M invested in Cue Health Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,673% more call options, than puts

Call options by funds: $195K | Put options by funds: $11K

20% less funds holding

Funds holding: 9979 (-20)

29% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 21

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

51% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 37

82% less capital invested

Capital invested by funds: $137M → $24.8M (-$113M)

Holders
79
Holders Change
-20
Holders Change %
-20.2%
% of All Funds
1.24%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
18
Increased
15
Reduced
21
Closed
37
Calls
$195K
Puts
$11K
Net Calls
+$184K
Net Calls Change
-$715K
Name Holding Trade Value Shares
Change
Change in
Stake
KI
1
Koch Industries
Kansas
$4.77M -$256K -299,991 -2%
OC
2
Oakmont Corp
California
$3.55M
DCMIC
3
Decheng Capital Management III (Cayman)
Cayman Islands
$3.32M
MA
4
Madrone Advisors
California
$2.61M
JJ
5
Johnson & Johnson
New Jersey
$2.05M
JPC
6
Jabodon PT Co
Nevada
$1.47M -$505K -591,580 -13%
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.43M -$394K -461,854 -11%
Temasek Holdings
8
Temasek Holdings
Singapore
$1.15M
BlackRock
9
BlackRock
New York
$532K -$4.43M -5,194,875 -78%
BL
10
Bleichroeder LP
New York
$369K
Verition Fund Management
11
Verition Fund Management
Connecticut
$369K +$854K +1,000,000 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$365K -$841K -985,614 -50%
Jacobs Levy Equity Management
13
Jacobs Levy Equity Management
New Jersey
$326K +$546K +639,501 +261%
Deutsche Bank
14
Deutsche Bank
Germany
$291K +$483K +565,772 +255%
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$275K +$299K +350,604 +89%
Squarepoint
16
Squarepoint
New York
$171K +$397K +464,716 New
Millennium Management
17
Millennium Management
New York
$168K +$390K +456,544 New
Goldman Sachs
18
Goldman Sachs
New York
$165K +$293K +343,766 +330%
MP
19
MSD Partners
New York
$146K
Renaissance Technologies
20
Renaissance Technologies
New York
$142K +$152K +177,800 +86%
YIH
21
Y-Intercept (HK)
Hong Kong
$123K +$284K +332,668 New
State Street
22
State Street
Massachusetts
$122K -$1.58M -1,850,676 -85%
Morgan Stanley
23
Morgan Stanley
New York
$114K +$147K +172,122 +126%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$97.1K +$150K +175,700 +201%
OMC
25
Old Mission Capital
Illinois
$94.9K +$219K +257,136 New

HLTH Hedge Fund Activity: Q2 2023 in Review

79 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Cue Health Inc. Common Stock (HLTH) for Q2 2023, worth a combined $24.8M — down 82% from $137M a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of HLTH and 18 opened new positions — a net loss of 19 holders — while 21 trimmed existing stakes and 15 added.

The largest buyer was Verition Fund Management, opening a new position worth an estimated $854K. The largest seller was BlackRock, cutting an estimated $4.43M.

  • 79 institutional investors held Cue Health Inc. Common Stock (HLTH) as of Q2 2023, down from 99 in Q1 2023.
  • Funds reported $24.8M of Cue Health Inc. Common Stock stock for Q2 2023, down 82% quarter-over-quarter.
  • 18 funds opened new Cue Health Inc. Common Stock positions in Q2 2023 and 37 closed out, a net change of -19 holders.
  • The largest Cue Health Inc. Common Stock buyer in Q2 2023 was Verition Fund Management, an estimated $854K added.
  • The largest Cue Health Inc. Common Stock seller in Q2 2023 was BlackRock, an estimated $4.43M sold.

Based on aggregated 13F filings for Q2 2023.